Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001754154-26-000010
Filing Date
2026-04-17
Accepted
2026-04-17 16:53:19
Documents
1
Period of Report
2026-04-15

Document Format Files

Seq Description Document Type Size
1 form4-04172026_080413.html 4  
1 form4-04172026_080413.xml 4 5318
  Complete submission text file 0001754154-26-000010.txt   7145
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O WHITEHAWK THERAPEUTICS, INC. 2 HEADQUARTERS PLAZA, EAST BUILDING, 11T MORRISTOWN NJ 07960
Business Address
Giacobello Scott M. (Reporting) CIK: 0001754154 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 26872356